SCHEMBL1421023

SCHEMBL1421023

C[C@@H]1C[C@@](C)(c2ccc(F)c(Br)c2)SC(NC(=O)OC(C)(C)C)=N1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.38
BRAF P15056 1/20 0.34
RORC P51449 4/20 0.32
IDO1 P14902 2/20 0.32
AAK1 Q2M2I8 2/20 0.32
LCK P06239 1/20 0.31
CCR2 P41597 1/20 0.31
CYP17A1 P05093 1/20 0.31
HCRTR1 O43613 1/20 0.30
HCRTR2 O43614 1/20 0.30
IDH1 O75874 2/20 0.30
USP30 Q70CQ3 1/20 0.30
SIRT2 Q8IXJ6 1/20 0.30
SIRT1 Q96EB6 1/20 0.30
SLC9A1 P19634 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1420814 0.90 BACE1 (0.35) BACE1BRAFRORCIDO1AAK1
SCHEMBL1420827 0.85 BACE1 (0.35) BACE1BRAFRORCAAK1LCK
SCHEMBL1420673 0.84 BACE1 (0.39) BACE1BRAFRORCCYP17A1
SCHEMBL1420882 0.84 HCRTR1 (0.36) BACE1AAK1LCKHCRTR1HCRTR2
SCHEMBL1421089 0.82 BRAF (0.33) BACE1BRAFRORCIDO1AAK1
SCHEMBL1421247 0.82 RAB9A (0.36) BACE1IDO1CCR2
SCHEMBL3187951 0.79 BRAF (0.34) BACE1BRAFRORCIDO1AAK1
SCHEMBL4307798 0.78 SLC9A1 (0.34) CCR2SLC9A1
SCHEMBL1420977 0.77 SYK (0.37) BACE1CCR2CYP17A1HCRTR1HCRTR2
SCHEMBL1421136 0.75 ABL1 (0.36) BACE1BRAFRORCCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297120-A1 AMINODIHYDROTHIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Eli Lilly & Company (US) 2011-03-23 EP disclosed
WO-2009134617-A1 AMINODIHYDROTHIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 2009-11-05 WO disclosed